These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. Rose PG; Adler LP; Rodriguez M; Faulhaber PF; Abdul-Karim FW; Miraldi F J Clin Oncol; 1999 Jan; 17(1):41-5. PubMed ID: 10458216 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer. Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401 [TBL] [Abstract][Full Text] [Related]
6. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Yeh LS; Hung YC; Shen YY; Kao CH; Lin CC; Lee CC Oncol Rep; 2002; 9(6):1289-92. PubMed ID: 12375036 [TBL] [Abstract][Full Text] [Related]
7. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660 [TBL] [Abstract][Full Text] [Related]
8. The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer. Umesaki N; Tanaka T; Miyama M; Kawabe J; Okamura T; Koyama K; Ochi H; Ogita S Oncol Rep; 2000; 7(6):1261-4. PubMed ID: 11032926 [TBL] [Abstract][Full Text] [Related]
9. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. Chou HH; Chang TC; Yen TC; Ng KK; Hsueh S; Ma SY; Chang CJ; Huang HJ; Chao A; Wu TI; Jung SM; Wu YC; Lin CT; Huang KG; Lai CH J Clin Oncol; 2006 Jan; 24(1):123-8. PubMed ID: 16382121 [TBL] [Abstract][Full Text] [Related]
10. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325 [TBL] [Abstract][Full Text] [Related]
11. Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan staging prior to planned radical hysterectomy and pelvic lymphadenectomy. Unger JB; Ivy JJ; Ramaswamy MR; Charrier A; Connor P Int J Gynecol Cancer; 2005; 15(6):1060-4. PubMed ID: 16343182 [TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Adams S; Baum RP; Stuckensen T; Bitter K; Hör G Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374 [TBL] [Abstract][Full Text] [Related]
14. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315 [TBL] [Abstract][Full Text] [Related]
15. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Reinhardt MJ; Ehritt-Braun C; Vogelgesang D; Ihling C; Högerle S; Mix M; Moser E; Krause TM Radiology; 2001 Mar; 218(3):776-82. PubMed ID: 11230656 [TBL] [Abstract][Full Text] [Related]
16. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy. Dräger DL; Heuschkel M; Protzel C; Erbersdobler A; Krause BJ; Hakenberg OW; Schwarzenböck SM Nuklearmedizin; 2018 Feb; 57(1):26-30. PubMed ID: 29536497 [TBL] [Abstract][Full Text] [Related]
17. Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study. Tanaka T; Sasaki S; Tsuchihashi H; Terai Y; Yamamoto K; Yamada T; Ohmichi M Medicine (Baltimore); 2018 Apr; 97(16):e0410. PubMed ID: 29668599 [TBL] [Abstract][Full Text] [Related]
18. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573 [TBL] [Abstract][Full Text] [Related]
19. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients. Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729 [TBL] [Abstract][Full Text] [Related]